Differential Effects of Alarmins on Human and Mouse Basophils

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2022 Jun 13

PMID 35693823

Authors

Adriana R Gambardella

Remo Poto

Valentina Tirelli

John T Schroeder

Gianni Marone

Fabrizio Mattei

Gilda Varricchi

Giovanna Schiavoni

Affiliations

Soon will be listed here.

Abstract

Epithelial-derived alarmins (IL-33, TSLP, and IL-25) play an upstream role in the pathogenesis of asthma. Basophil-derived cytokines are a pivotal component of allergic inflammation. We evaluated the effects of IL-33, TSLP, and IL-25, alone and in combination with IL-3 on purified peripheral blood human basophils (hBaso) and bone marrow-derived mouse basophils (mBaso) in modulating the production of IL-4, IL-13, CXCL8 or the mouse CXCL8 equivalents CXCL1 and CXCL2. IL-3 and IL-33, but not TSLP and IL-25, concentration-dependently induced IL-4, IL-13, and CXCL8 release from hBaso. IL-3 synergistically potentiated the release of cytokines induced by IL-33 from hBaso. In mBaso, IL-3 and IL-33 rapidly induced IL-4 and IL-13 mRNA expression and protein release. IL-33, but not IL-3, induced CXCL2 and CXCL1 from mBaso. Differently from hBaso, TSLP induced IL-4, IL-13, CXCL1 and CXCL2 mRNA expression and protein release from mBaso. IL-25 had no effect on IL-4, IL-13, and CXCL1/CXCL2 mRNA expression and protein release even in the presence of IL-3. No synergism was observed between IL-3 and either IL-25 or TSLP. IL-3 inhibited both TSLP- and IL-33-induced CXCL1 and CXCL2 release from mBaso. Our results highlight some similarities and marked differences between the effects of IL-3 and alarmins on the release of cytokines from human and mouse basophils.

Citing Articles

Basophils may as a risk factor for upper gastrointestinal cancer: a Mendelian randomization (MR) study.

Nov P, Li W, Wang D, Touch S, Kouy S, Ni P Ecancermedicalscience. 2025; 18():1799.

PMID: 39816393 PMC: 11735140. DOI: 10.3332/ecancer.2024.1799.

From the bench to the clinic: basophils and type 2 epithelial cytokines of thymic stromal lymphopoietin and IL-33.

Obata-Ninomiya K, Jayaraman T, Ziegler S Clin Transl Immunology. 2024; 13(12):e70020.

PMID: 39654685 PMC: 11626414. DOI: 10.1002/cti2.70020.

The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cells.

Poto R, Cristinziano L, Criscuolo G, Strisciuglio C, Palestra F, Lagnese G Front Immunol. 2024; 15:1443704.

PMID: 39188724 PMC: 11345246. DOI: 10.3389/fimmu.2024.1443704.

Innate Immune Cells in Melanoma: Implications for Immunotherapy.

Trocchia M, Ventrici A, Modestino L, Cristinziano L, Ferrara A, Palestra F Int J Mol Sci. 2024; 25(15).

PMID: 39126091 PMC: 11313504. DOI: 10.3390/ijms25158523.

Cytokines and chemokines skin gene expression in correlation with immune cells in blood and severity in equine insect bite hypersensitivity.

Jebbawi F, Chemnitzer A, Dietrich M, Pantelyushin S, Lam J, Rhiner T Front Immunol. 2024; 15:1414891.

PMID: 39076967 PMC: 11284025. DOI: 10.3389/fimmu.2024.1414891.

References

Salter B, Oliveria J, Nusca G, Smith S, Watson R, Comeau M . Thymic stromal lymphopoietin activation of basophils in patients with allergic asthma is IL-3 dependent. J Allergy Clin Immunol. 2015; 136(6):1636-1644. DOI: 10.1016/j.jaci.2015.03.039. View

Schroeder J, Chichester K, Bieneman A . Human basophils secrete IL-3: evidence of autocrine priming for phenotypic and functional responses in allergic disease. J Immunol. 2009; 182(4):2432-8. PMC: 2704022. DOI: 10.4049/jimmunol.0801782. View

Menzies-Gow A, Corren J, Bourdin A, Chupp G, Israel E, Wechsler M . Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma. N Engl J Med. 2021; 384(19):1800-1809. DOI: 10.1056/NEJMoa2034975. View

De Monte L, Wormann S, Brunetto E, Heltai S, Magliacane G, Reni M . Basophil Recruitment into Tumor-Draining Lymph Nodes Correlates with Th2 Inflammation and Reduced Survival in Pancreatic Cancer Patients. Cancer Res. 2016; 76(7):1792-803. DOI: 10.1158/0008-5472.CAN-15-1801-T. View

Siracusa M, Saenz S, Hill D, Kim B, Headley M, Doering T . TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation. Nature. 2011; 477(7363):229-33. PMC: 3263308. DOI: 10.1038/nature10329. View

Li X, Bechara R, Zhao J, McGeachy M, Gaffen S . IL-17 receptor-based signaling and implications for disease. Nat Immunol. 2019; 20(12):1594-1602. PMC: 6943935. DOI: 10.1038/s41590-019-0514-y. View

McGeachy M, Cua D, Gaffen S . The IL-17 Family of Cytokines in Health and Disease. Immunity. 2019; 50(4):892-906. PMC: 6474359. DOI: 10.1016/j.immuni.2019.03.021. View

Siracusa M, Kim B, Spergel J, Artis D . Basophils and allergic inflammation. J Allergy Clin Immunol. 2013; 132(4):789-801. PMC: 3903395. DOI: 10.1016/j.jaci.2013.07.046. View

Sharma M, Das M, Stephen-Victor E, Galeotti C, Karnam A, Maddur M . Regulatory T cells induce activation rather than suppression of human basophils. Sci Immunol. 2018; 3(23). DOI: 10.1126/sciimmunol.aan0829. View

10.

Weng C, Wang C, Lee M, He J, Huang H, Chao M . Aryl hydrocarbon receptor activation by diesel exhaust particles mediates epithelium-derived cytokines expression in severe allergic asthma. Allergy. 2018; 73(11):2192-2204. DOI: 10.1111/all.13462. View

11.

Lee H, Headley M, Loo Y, Berlin A, Gale Jr M, Debley J . Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection. J Allergy Clin Immunol. 2012; 130(5):1187-1196.e5. PMC: 4284103. DOI: 10.1016/j.jaci.2012.07.031. View

12.

Akdis C . Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?. Nat Rev Immunol. 2021; 21(11):739-751. DOI: 10.1038/s41577-021-00538-7. View

13.

Mali S, Bautista D . Basophils add fuel to the flame of eczema itch. Cell. 2021; 184(2):294-296. DOI: 10.1016/j.cell.2020.12.035. View

14.

Hayes M, Ward S, Crawford G, Castro Seoane R, Jackson W, Kipling D . Inflammation-induced IgE promotes epithelial hyperplasia and tumour growth. Elife. 2020; 9. PMC: 6959995. DOI: 10.7554/eLife.51862. View

15.

Smithgall M, Comeau M, Yoon B, Kaufman D, Armitage R, Smith D . IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int Immunol. 2008; 20(8):1019-30. DOI: 10.1093/intimm/dxn060. View

16.

Kato A, Favoreto Jr S, Avila P, Schleimer R . TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells. J Immunol. 2007; 179(2):1080-7. PMC: 2220044. DOI: 10.4049/jimmunol.179.2.1080. View

17.

Martin N, Martin M . Interleukin 33 is a guardian of barriers and a local alarmin. Nat Immunol. 2016; 17(2):122-31. DOI: 10.1038/ni.3370. View

18.

MacGlashan Jr D, Saini S, Schroeder J . Response of peripheral blood basophils in subjects with chronic spontaneous urticaria during treatment with omalizumab. J Allergy Clin Immunol. 2021; 147(6):2295-2304.e12. DOI: 10.1016/j.jaci.2021.02.039. View

19.

Miura K, MacGlashan Jr D . Dual phase priming by IL-3 for leukotriene C4 generation in human basophils: difference in characteristics between acute and late priming effects. J Immunol. 2000; 164(6):3026-34. DOI: 10.4049/jimmunol.164.6.3026. View

20.

Ochensberger B, Daepp G, Rihs S, Dahinden C . Human blood basophils produce interleukin-13 in response to IgE-receptor-dependent and -independent activation. Blood. 1996; 88(8):3028-37. View